Literature DB >> 22362648

An analysis of predictive markers for intracranial haemorrhage in warfarinised head injury patients.

Simon Rendell1, John S Batchelor.   

Abstract

INTRODUCTION: Minor head injury in older patients on warfarin may present in a variety of ways that often fall outside the remit of conventional guidelines. The aim of this study was to determine the relative risks for intracranial haemorrhage (ICH) in patients with subtherapeutic, therapeutic and supratherapeutic INR levels, in addition to the relative risks for the common symptoms at presentation.
METHODS: The notes were retrospectively reviewed of all patients who had a CT scan requested by the emergency department over a 2-year period (January 2008 to December 2009) and from these warfarinised head injuries were identified.
RESULTS: 82 warfarinised head injury patients were identified from 3338 requested CT scans. 12 of these patients (15%) had evidence of ICH on the CT. 72 patients had their INR checked (88%) and the RR of ICH for the INR subgroups were calculated: INR <2 (RR 1.89; 95% CI 0.65 to 5.55); INR 2-3 (RR 0.84; 95% CI 0.27 to 2.64); and INR >3 (RR 0.53; 95% CI 0.13 to 2.29). The greatest proportion of those with ICH (42%) had a subtherapeutic INR. 2 out of the 12 patients (17%) were found to have intracranial bleeding despite not meeting the criteria for a CT scan according to the NICE guidelines.
CONCLUSION: The results of the INR subgroup analysis suggest that a subtherapeutic INR may not be protective against ICH in patients with minor head injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362648     DOI: 10.1136/emermed-2011-200176

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  2 in total

Review 1.  A review of anticoagulation in patients with central nervous system malignancy: between a rock and a hard place.

Authors:  Dawn Swan; David Julian Seiffge; Jecko Thachil
Journal:  J Neurol       Date:  2020-03-02       Impact factor: 4.849

2.  AHEAD Study: an observational study of the management of anticoagulated patients who suffer head injury.

Authors:  Suzanne Mason; Maxine Kuczawski; M Dawn Teare; Matt Stevenson; Steve Goodacre; Shammi Ramlakhan; Francis Morris; Joanne Rothwell
Journal:  BMJ Open       Date:  2017-01-13       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.